Ivonescimab Plus Chemotherapy for NSCLC With an EGFR Variant
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ivonescimab Plus Chemotherapy in Non-Small Cell Lung Cancer With EGFR Variant: A Randomized Clinical Trial
JAMA 2024 May 31;[EPub Ahead of Print], W Fang, Y Zhao, Y Luo, R Yang, Y Huang, Z He, H Zhao, M Li, K Li, Q Song, X Du, Y Sun, W Li, F Xu, Z Wang, K Yang, Y Fan, B Liu, H Zhao, Y Hu, L Jia, S Xu, T Yi, D Lv, H Lan, M Li, W Liang, Y Wang, H Yang, Y Jia, Y Chen, J Lu, J Feng, C Liu, M Zhou, J Zhou, X Liu, N Zhou, M He, X Dong, H Chen, Y Chen, H Su, X Li, Z Zhang, L Yang, Y Cheng, L Chen, X Hou, Y Zhang, J Guo, Z Wang, H Lu, D Wu, W Feng, W Li, J Huang, Y Wang, X Song, J Peng, L Liu, Y Guo, W Li, D Lu, M Hu, ZM Wang, B Li, M Xia, L ZhangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.